Mariano
Ponz Sarvisé
Consultor Médico
Tel Aviv University
Tel Aviv, IsraelPublicaciones en colaboración con investigadores/as de Tel Aviv University (1)
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885